BioMarin Begins Mid Stage Study on Gene Therapy Candidate – Zacks.com
Zacks.comBioMarin Begins Mid Stage Study on Gene Therapy CandidateZacks.comThe candidate enjoys Breakthrough Therapy designation in the United States. This designation facilitates and expedites development and review of new drugs to address unmet medic… Continue reading
